- Antibiotic Stewardship
Improve patient outcomes with appropriate antibiotic usage
Optimize the treatment of infections, reduce adverse events and avoid costly penalties associated with antibiotic use
A Robust Antibiotic Stewardship Program (ASP)
Since the 1940s, antibiotic drugs have greatly reduced illness and death from infectious diseases. However, these drugs have been used so widely and for so long that the infectious organisms the antibiotics are designed to kill have adapted to them, making the drugs less effective. Antibiotic-resistant bacteria are responsible for infecting at least two million people annually in the United States and at least 23,000 people die due to these infections.1
The CDCs Core Elements
Half of all small hospitals in the U.S. currently meet the CDC’s core elements for ASP. As the CDC states, a growing body of evidence demonstrates that hospital-based programs dedicated to ASP can both optimize the treatment of infections and reduce adverse events associated with antibiotic use.2, 3
$35-45B
cost of Hospital Acquired Infections (HAI) to hospitals
12 M
people are misdiagnosed each year
1 in 25
patients acquire an HAI everyday
≤50%
of antibiotic prescriptions are necessary
18%
of patients are readmitted within 30 days
Slow the spread of infection with aggressive diagnostics
According to the CDC, more than 2.8 million antimicrobial-resistant infections occur in the U.S. each year resulting in over 35,000 patient deaths.6 A study conducted by the Washington University School of Medicine in St. Louis revealed that anywhere from 30% to 50% of antibiotics used in hospitalized adults were inappropriate.7
Accurate and reliable diagnostics for resistant infections are vital in slowing the spread of disease and keeping your patients healthy. The National Action Plan, developed by The U.S. Department of Health and Human Services (HHS) as an overall plan of attack for preventing the spread of antimicrobial resistance, lists rapid diagnostic tests for identification and characterization of resistant bacteria as one of five key measures to combat inappropriate antibiotic use.8
A solution for antibiotic stewardship
Our goal is to support patient safety and conserve antibiotics in all communities nationwide by offering solutions that help augment the good work hospitals have already implemented. Our experienced team will work closely with stewardship teams to move from the current state to a jointly defined ideal state.
Watch our webinar and panel presentation on how the core elements of an antibiotic stewardship program help reduce hospital-acquired infections, patient length of stay and improve overall patient satisfaction.4,5
Diagnostic Resources
You can count on our accurate, fast and reliable diagnostics resources to strengthen your antibiotic stewardship practice. McKesson has exclusive alliances with manufacturers to offer a diagnostics suite that affords providers and clinical decision-makers the results necessary to help move patients from ‘clinical suspicion’ to ‘end of therapy’ hours or even days sooner than some traditional methods.
Address common challenges:
- Limited diagnostics capability: microbiology, molecular and other lab testing platforms
- Short staff and skilled labor challenges
- Hospital-wide cost reduction initiatives
Aggressive diagnostics can help you achieve:
- Quicker decisions for faster treatment
- Precise antibiotic therapy for better results
- Timely patient education for greater satisfaction
Taking Action for Optimal Antibiotic Use
The White House Forum on Antibiotic Stewardship brought together more than 100 key human and animal health leaders to plan the development, promotion and implementation of activities to promote optimal use of antibiotics nationwide. Together, they put forth a national antibiotic stewardship action plan that included:
50% reduction of C. difficile incidents with more automation
60% reduction in hospital-acquired Carbapenem-resistant Enterobacterales (CRE) infections
35% reduction in hospital-acquired multidrug-resistant pseudomonas species infections
50% reduction in Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections
50% reduction in inappropriate antibiotic use in outpatient settings
20% reduction in inappropriate antibiotic use in inpatient settings
Improve patient outcomes and access diagnostic resources
Contact our lab specialists to learn how our solution for antibiotic stewardship can help you work towards these goals and make a positive impact in patient therapy.
1 – https://www.cdc.gov/drugresistance/index.html
2 – https://www.cdc.gov/antibiotic-use/healthcare/implementation/core-elements.html#_ENREF_17
3 – https://www.cdc.gov/antibiotic-use/healthcare/implementation/core-elements.html#_ENREF_18
4 – Hecker MT, Fox CJ, Son AH, et al. Effect of a stewardship intervention on adherence to uncomplicated cystitis and pyelonephritis guidelines in an emergency department setting. PLoS One. 2014;9(2):e87899. doi:10.137/journal.pone.0087899.
5 – Johnstone J, Mandell L. Guidelines and quality measures: do they improve outcomes of patients with community-acquired pneumonia? Infect Dis Clin North Am. 2013;27(1):71-86. doi:10.1016/j.idc.2012.11.001.
6 – https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf
7 – https://medicine.wustl.edu/news/1-in-4-kids-who-get-antibiotics-in-childrens-hospitals-are-prescribed-the-drugs-incorrectly/
8 – https://www.cdc.gov/drugresistance/us-activities/national-action-plan.html
$35B to $45B – https://www.cdc.gov/hai/pdfs/hai/scott_costpaper.pdf
12M – https://qualitysafety.bmj.com/content/early/2014/04/04/bmjqs-2013-002627
1 in 25 – https://www.cdc.gov/hai/surveillance/index.html
Only 49% – https://www.pharmacytoday.org/article/S1042-0991(17)31637-7/pdf
50% – https://www.cdc.gov/antibiotic-use/stewardship-report/pdf/stewardship-report.pdf
18% – https://www.hcup-us.ahrq.gov/reports/statbriefs/sb196-Readmissions-Trends-High-Volume-Conditions.pdf
Be advised that information contained herein is intended to serve as a useful reference for informational purposes only and is not complete clinical information. This information is intended for use only by competent healthcare professionals exercising judgment in providing care. McKesson cannot be held responsible for the continued currency of or for any errors or omissions in the information.
The product information contained in this document, including the product images and additional product materials, was collected from various supplier sources. All product claims and specifications are those of the product suppliers and have not been independently verified by McKesson Medical-Surgical or its affiliates (“McKesson”). McKesson is not responsible for errors or omissions in the product information. The properties of a product may change or be inaccurate following the posting or printing of the product information in the document, either in the print or online version. Caution should be exercised when using or purchasing any products from McKesson’s online or print documents by closely examining the product packaging and the labeling prior to use. Due to product changes, information listed in this document is subject to change without notice. This information is placed solely for your convenience in ordering and McKesson disclaims all responsibility for its completeness and accuracy, whether or not the inaccuracy or incompleteness is due to fault or error by McKesson.
©2024 McKesson Medical-Surgical Inc. All trademarks and registered trademarks are the property of their respective owners.